Getinge plans to phase out its surgical perfusion business in a move expected to benefit major players such as LivaNova, ...

Welcome to the AVITA Medical fourth-quarter 2024 earnings conference call. (Operator Instructions) Please be advised that today's conference is being recorded. I would now like to hand the conference ...

An American College of Surgeons initiative reduced postoperative hospitalization among older adults with cancer, according to ...

Specialty pharmaceutical companies Cumberland Pharmaceuticals Inc. and SciClone Pharmaceuticals (Holdings) Limited ("SciClone Pharmaceuticals" or "SciClone") today announced the NMPA (National Medical ...

Jerusalem: MediWound, an Israeli developer of products to treat burns and wounds using non-surgical tissue repair, said on Wednesday it was starting a Phase III ... with over 1.5 million new ...

The backlash is largely stemming from Pohutsky’s politicization of an intimate decision between a husband and wife, but the ...

A New Beginning for Human Development," has announced the results of its efforts following the first 100 days since its ...

Light AI Inc. ("Light AI" or the "Company") (CBOE CA: ALGO / FSE: 0HC), a global healthcare technology company focused on developing artificial intelligence health diagnostic and wellness solutions, ...

Rezolute advances therapies for hypoglycemia with RZ358 and RZ402, showing efficacy in trials. Read why RZLT stock is a ...

The State Health Plan's Board of Trustees authorized staff to flesh out a proposal that would base the percentage increase of ...

(NASDAQ:BDRX), a clinical-stage biopharmaceutical company developing a pipeline of innovative products for the treatment of diseases with unmet medical ... month data from a phase 2 clinical ...

CARDIFF, UK / ACCESS Newswire / February 12, 2025 / Biodexa Pharmaceuticals PLC. (NASDAQ:BDRX), a clinical-stage biopharmaceutical company developing a pipeline of innovative products for the treatmen ...